Positive opinion issued to broaden use of Erbitux, including first-line colorectal cancer June 9, 2008
EMEA recommends that new warnings be included in product information for Novartis' Sebivo Feb. 19, 2008
EMEA recommends suspension of marketing authorization of medicines containing aprotinin Nov. 23, 2007
RSS